Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
McKinsey
Medtronic
US Department of Justice
Moodys
Boehringer Ingelheim
Cipla
Healthtrust
UBS
Chubb

Generated: August 18, 2017

DrugPatentWatch Database Preview

SODIUM PENTOBARBITAL Drug Profile

« Back to Dashboard

Which patents cover Sodium Pentobarbital, and what generic Sodium Pentobarbital alternatives are available?

Sodium Pentobarbital is a drug marketed by Purepac Pharm, Nexgen Pharma Inc, Wyeth Ayerst, Parke Davis, Everylife, Perrigo, Ivax Sub Teva Pharms, Valeant Pharm Intl, Elkins Sinn, Halsey, Anabolic, and Watson Labs. and is included in thirteen NDAs.

The generic ingredient in SODIUM PENTOBARBITAL is pentobarbital sodium. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.

Summary for Tradename: SODIUM PENTOBARBITAL

Patents:0
Applicants:12
NDAs:13
Bulk Api Vendors: see list47
Clinical Trials: see list2,378
Patent Applications: see list9,802
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SODIUM PENTOBARBITAL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purepac Pharm
SODIUM PENTOBARBITAL
pentobarbital sodium
CAPSULE;ORAL083301-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
SODIUM PENTOBARBITAL
pentobarbital sodium
CAPSULE;ORAL083461-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
SODIUM PENTOBARBITAL
pentobarbital sodium
CAPSULE;ORAL084156-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Halsey
SODIUM PENTOBARBITAL
pentobarbital sodium
CAPSULE;ORAL084677-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
SODIUM PENTOBARBITAL
pentobarbital sodium
CAPSULE;ORAL083461-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Chubb
Citi
Harvard Business School
Colorcon
US Army
Farmers Insurance
Cipla
QuintilesIMS
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot